Radiation-induced optic neuropathy. (2008 study) Skip to main content
Clinical Study Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2008

Radiation-induced optic neuropathy.

Danesh-Meyer HV, Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2008

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The author wrote a review of radiation-induced optic neuropathy, a late complication of radiotherapy that damages the nerves carrying vision from the eye to the brain.

What They Found

This review describes radiation-induced optic neuropathy as a late complication of radiotherapy to the anterior visual pathway that causes acute, profound, irreversible visual loss, and it usually needs cumulative doses above 50 Gy or single doses above 10 Gy. Vision loss most often starts between 10 and 20 months after treatment, averaging 18 months, but onset ranges from three months to 9 years. Higher risk is linked to age, tumour pressing on the optic nerve and chiasm, concurrent chemotherapy, or earlier external beam radiation. The abstract states that treatment with systemic corticosteroids, anticoagulation and hyperbaric oxygen has been generally unsuccessful and disappointing. It also says that if visual problems are caught early, hyperbaric oxygen might be beneficial if started within 72 hours of visual loss.

What This Means for Canadian Patients

For people who have had radiotherapy near the visual pathway, the abstract points to early detection as important, since MRI may show changes before vision is lost. Hyperbaric oxygen has generally been disappointing for this condition, and the abstract says it might help only when started within 72 hours of visual loss. Because the outlook is poor, the abstract says the risk of this complication should be weighed when deciding whether to irradiate the brain.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The abstract describes a narrative review rather than a trial, reports no new patient data or comparison of treatments, and the possible benefit of hyperbaric oxygen within 72 hours is stated only as something that "might" occur.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Radiation Injury
Source Pubmed
PubMed ID 18068989
Year Published 2008
Journal Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
MeSH Terms Humans; Optic Nerve Diseases; Radiation Injuries; Radiotherapy; Radiotherapy Dosage

Cite This Study

Share

This study relates to Delayed Radiation Injury. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Radiation Injury

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology